12:14:12 EDT Fri 13 Jun 2025
Enter Symbol
or Name
USA
CA



Login ID:
Password:
Save

T:MDP - MEDEXUS PHARMACEUTICALS INC. J - https://www.medexus.ca/
Sym-XBid - AskLastChg%ChVol$Vol#TrOpen-Hi-LoYear Hi-LoLast TrNewsDelay
MDP - T  0.52.95·2.960.42.97+0.041.46.217222.95  2.97  2.9455.56  1.5211:19:25Apr 1715 min RT 2¢
TSX - T0.52.95·2.960.42.96+0.031.03.91172.95  2.96  2.955.56  1.5211:12:3615 min
NEO ATS - U 2.95+0.020.70.1012.95  2.95  2.9510:01:2415 min
CXD - D 2.95+0.020.70.2032.945  2.95  2.94510:01:2415 min
TriAct - M 2.930.518    Sep 11-2015 min
Lynx - Y 2.97+0.041.41.5432.95  2.97  2.9511:19:2515 min

Recent Trades - Last 10 of 22
Time ETExPriceChangeVolumeBuyerSellerMarkers
11:31:49M2.970.049179 CIBC79 CIBCE
11:28:21M2.950.02180 National Bank80 National BankE
11:19:25M2.970.04579 CIBC79 CIBCE
11:19:25Y2.970.0450079 CIBC79 CIBCK
11:17:14M2.970.047179 CIBC79 CIBCE
11:12:36T2.960.031001 Anonymous79 CIBCK
11:05:07M2.950.0210084 ITG8479 CIBC
10:08:28T2.950.021,40085 Scotia79 CIBCK
10:08:28T2.950.022,00085 Scotia1 AnonymousK
10:01:24T2.950.0210085 Scotia79 CIBCK

Sign-up for a FREE 30-day Stockwatch subscription and SEE NO ADS

Recent Bulletins
Date ETSymbolPriceTypeHeadline
2025-04-17 16:34C:MDP2.55News ReleaseMedexus completes listing agreement for Trecondyv
2025-04-07 16:19C:MDP2.17News ReleaseMedexus talks up market response to Grafapex
2025-03-14 14:15C:MDP2.57News ReleaseMedexus completes cancellation of Gleolan U.S. licence
2025-02-24 16:32C:MDP2.98News ReleaseMedexus's Grafapex for injection available in U.S.
2025-02-07 05:42C:MDP3.21In the NewsGlobe says Medexus Pharmaceuticals lowered to "hold"
2025-02-06 10:51C:MDP3.79News ReleaseCanadian Investment Regulatory Organization Trade Resumption - MDP
2025-02-06 10:45C:MDP3.79News ReleaseCanadian Investment Regulatory Organization Trading Halt - MDP
2025-02-06 10:35C:MDP3.79Resume TradingMedexus Pharmaceuticals to resume at 7:36 a.m. PT
2025-02-06 10:34C:MDP3.79Halt TradingMedexus Pharmaceuticals halted at 7:31 a.m. PT
2025-02-05 17:39C:MDP3.79SEDAR Interim MD & ASEDAR Interim MD & A
2025-02-05 17:38C:MDP3.79SEDAR Interim Financial StatementsSEDAR Interim Financial Statements
2025-02-05 17:31C:MDP3.79News ReleaseMedexus Announces Strong Fiscal Q3 2025 Results, Well-Positioned to Launch GRAFAPEX (treosulfan) for Injection in the United States
2025-02-04 17:54C:MDP3.87News ReleaseMedexus completes listing agreements with Ontario
2025-01-31 18:21C:MDP3.85News ReleaseMedexus to release fiscal Q3 results Feb. 5
2025-01-31 16:44C:MDP3.85News ReleaseMedexus Pharmaceuticals closes $30-million offering
2025-01-29 20:27C:MDP4.00Prospectus ApprovedMedexus Pharmaceuticals to list 7.5 million more shares
2025-01-28 10:00C:MDP4.60News ReleaseMedexus Pharmaceuticals prices $30M overnight offering
2025-01-28 09:47C:MDP4.60News ReleaseCanadian Investment Regulatory Organization Trade Resumption - MDP
2025-01-28 09:36C:MDP4.60Resume TradingMedexus Pharmaceuticals to resume at 7 a.m. PT
2025-01-27 16:11C:MDP4.60News ReleaseMedexus arranges overnight public offering of shares